A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report

Creative Commons License

ONSUN N., KAYA G., IŞIK B. G., GÜNEŞ B.

HEALTH PROMOTION PERSPECTIVES, vol.11, no.2, pp.261-262, 2021 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.34172/hpp.2021.32
  • Journal Name: HEALTH PROMOTION PERSPECTIVES
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Page Numbers: pp.261-262
  • Keywords: CoronoVac, COVID, Psoriasis
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

CoronoVac is a non-viable vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nowadays, there has been vaccination program for at-risk groups and older adults in Turkey. We here present 72-year-old male psoriasis patient who developed generalized pustular psoriasis flare after administration of CoronoVac. The COVID-PCR test was negative and investigations for flare etiology were all normal. He was first (to the best of our knowledge) psoriasis patient who developed an erythrodermic flare after the first dose of CoronaVac vaccine.